Posttransplant diabetes - Metabolic consequences of posttransplant immunosuppressive treatment;Posttransplantationsdiabetes - Metaboliske konsekvenser af immunsuppression efter organtransplantation

Ugeskrift for Laeger

Volumn 169, Issue 24, 2007, Pages 2309-2311

  Christiansen, Erik ^a  

^a ROSKILDE HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; IMMUNOSUPPRESSIVE AGENT;

CHEMICALLY INDUCED DISORDER; DIABETES MELLITUS; HUMAN; METABOLISM; ORGAN TRANSPLANTATION; PRACTICE GUIDELINE; REVIEW; RISK FACTOR;

DIABETES COMPLICATIONS; DIABETES MELLITUS; HUMANS; HYPOGLYCEMIC AGENTS; IMMUNOSUPPRESSIVE AGENTS; ORGAN TRANSPLANTATION; PRACTICE GUIDELINES; RISK FACTORS;

EID: 34250713952     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (10)

1. Kasiske BL, Snyder JJ, Gilbertson D et al. Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 2003;3:178-85.
2. Cosio FG, Kudva Y, van der Velde M et al. New onset hyperglycemia and diabetes are associated with increased cardiovascular risk after kidney transplantation. Kidney Int 2005;67:2415-21.
3. Hjelmesaeth J, Hartmann A, Leivestad T et al. The impact of early-diagnosed new-onset post-transplantation diabetes mellitus on survival and major cardiac events. Kidney Int 2006;69:588-95.
4. Wilkinson A, Davidson J, Dotta F et al. Guidelines for the treatment and management of new-onset diabetes after transplantation. Clin Transplant 2005;19:291-8.
5. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003;26:3160-7.
6. Montori VM, Basu A, Erwin PJ et al. Posttransplantation Diabetes: a systematic review of the literature. Diabetes Care 2002;25:583-92.
7. Luzi L, Secchi A, Facchini F et al. Reduction of insulin resistance by combined kidney-pancreas transplantation in Type 1 (insulin-dependent) diabetic patients. Diabetologia 1990;33:549-56.
8. Christiansen E, Vesteraard H, Tibell A et al. Impaired insulin-stimulated nonoxidative glucose metabolism in pancreas-kidney transplant recipients. Doseresponse effects of insulin on glucose turnover. Diabetes 1996;45:1267-75.
9. Egidi FG. Management of hyperglycaemia after pancreas transplantation: are new immunosuppressants the answer? Drugs 2005;65:153-66.
10. Wenke K, Meiser B, Thiery J et al. Simvastatin initiated early after heart transplantation: 8-year prospective experience. Circulation 2003;107:93-7.